Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune ...
Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer, effective Feb. 15. She succeeds longtime CEO Maryann Roefaro, who is retiring from the position ...
About 100 students from Apollo High School will raise money for cancer treatment Sunday, when the students hold their annual DanceBlue Marathon from 4 p.m. to midnight at AHS. The event is a ...
Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...
Delaware-based Incyte Corporation (INCY) focuses on the discovery, development, and commercialization of therapeutics for ...
Individualized treatments for cancer show great promise, and three KC-area providers are dialing up their offerings.
Every year, roughly 14,000 women are diagnosed with cervical cancer and out of that number, nearly 4,400 will pass away from the disease. With January being Cervical Cancer Awareness Month, we ...
The FDA has banned Red Dye No. 3, citing cancer risk concerns. The removal from the supply chain may take over a year, ...
Drs. Kuang S. Chang, Frederick L. Flynt Jr., Jonathan Hsu, and Ashley Ray receive peer-driven honorATHENS, Ga., Jan. 15, 2025 (GLOBE NEWSWIRE) ...
A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in ...
DeWITT, N.Y. — Hematology-Oncology Associates of CNY (HOA) has appointed Jennifer Pichoske as its next CEO, effective Feb. 15 ...